Action Point Financial Planning’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Action Point Financial Planning's ARKG Position: Q3 2026 in Review
Action Point Financial Planning sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2026, closing a stake of 27 shares — an estimated $1.14K sold.
Action Point Financial Planning first reported a position in ARKG in Q2 2026 and held it in 1 quarter. The position peaked at $1.14K in Q2 2026. 316 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.
- Action Point Financial Planning reported no remaining ARK Genomic Revolution ETF position as of Q3 2026 after selling out during the quarter.
- Action Point Financial Planning sold 27 ARK Genomic Revolution ETF shares in Q3 2026, an estimated $1.14K.
- Action Point Financial Planning first reported a position in ARK Genomic Revolution ETF in Q2 2026 and held it in 1 quarter.
- Action Point Financial Planning's ARK Genomic Revolution ETF position peaked at $1.14K in Q2 2026.
- 316 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.
Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.